Cover |
Jun. 23, 2022 |
|---|---|
| Document Type | 8-K/A |
| Amendment Flag | true |
| Amendment Description | This Amendment No. 1 on Form 8-K/A amends the Current Report on Form 8-K of Pasithea Therapeutics Corp. (the “Company”) filed with the U.S. Securities and Exchange Commission on June 23, 2022 (the “Original Form 8-K”). The Original Form 8-K reported the Company’s election results at its annual meeting of shareholders (the “Meeting”). The purpose of this amendment is to (i) revise the term “Abstain” to “Withheld” with regard to the director election proposal in order to conform with the language used in the Company’s Proxy Statement, and (ii) to report the number of Broker Non-Votes on each matter. No other changes have been made to the Original Form 8-K. |
| Document Period End Date | Jun. 23, 2022 |
| Entity File Number | 001-40804 |
| Entity Registrant Name | Pasithea Therapeutics Corp. |
| Entity Central Index Key | 0001841330 |
| Entity Tax Identification Number | 85-1591963 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 1111 Lincoln Road |
| Entity Address, Address Line Two | Suite 500 |
| Entity Address, City or Town | Miami Beach |
| Entity Address, State or Province | FL |
| Entity Address, Postal Zip Code | 33139 |
| City Area Code | (702) |
| Local Phone Number | 514-4174 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
| Common stock, par value $0.0001 per share | |
| Title of 12(b) Security | Common stock, par value $0.0001 per share |
| Trading Symbol | KTTA |
| Security Exchange Name | NASDAQ |
| Warrants to purchase common stock, par value $0.0001 per share | |
| Title of 12(b) Security | Warrants to purchase common stock, par value $0.0001 per share |
| Trading Symbol | KTTAW |
| Security Exchange Name | NASDAQ |